| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/31/2001 | CA2392362A1 Novel methods and compositions involving opioids and antagonists thereof |
| 05/31/2001 | CA2392327A1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 05/31/2001 | CA2392225A1 Novel il-8 receptor antagonists |
| 05/31/2001 | CA2392217A1 Methods of inhibiting atrophy or promoting hypertrophy |
| 05/31/2001 | CA2392175A1 A conjugate of a collagen ii-binding fragment and an arthritis-affecting pharmaceutical substance |
| 05/31/2001 | CA2391606A1 Modular targeted liposomal delivery system |
| 05/31/2001 | CA2391499A1 Compositions and methods for treatment of allergic disorders |
| 05/31/2001 | CA2391012A1 Pyrazinone thrombin inhibitors |
| 05/31/2001 | CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | CA2390724A1 Combination of fluazuron and invermectin for parasite control |
| 05/31/2001 | CA2390465A1 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2389537A1 Mixture of pomegranate seed oil and juice products |
| 05/31/2001 | CA2388103A1 Medicament and combination of compatible medicaments |
| 05/31/2001 | CA2387591A1 Use of indirubine derivatives for making medicines |
| 05/31/2001 | CA2386955A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 05/30/2001 | EP1103562A1 Novel g-protein coupled receptor protein and dna thereof |
| 05/30/2001 | EP1103545A1 2-(3,5-Bis-trifluoromethyl-phenyl)-N-methyl-N-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide |
| 05/30/2001 | EP1103544A2 Piperidine derivatives and antiplatelet agents containing the same |
| 05/30/2001 | EP1103264A2 Active oxygen containing solution for promoting growth of tissue cells at wound sites |
| 05/30/2001 | EP1103181A1 Combination of N-phenyl-N'-benzoyl urea derivatives and avermectine compounds for parasite control |
| 05/30/2001 | EP1102855A1 Method for producing plants with increased flavonoid and phenolic compound content |
| 05/30/2001 | EP1102842A2 Antisense oligonucleotides for the inhibition of vegf expression |
| 05/30/2001 | EP1102838A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 05/30/2001 | EP1102789A1 Monocyclic compounds having nk-2 antagonist action and compositions containing them |
| 05/30/2001 | EP1102783A1 Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom |
| 05/30/2001 | EP1102781A1 New cofactors for methyltransferases |
| 05/30/2001 | EP1102776A1 Water soluble prodrugs of hindered alcohols or phenols |
| 05/30/2001 | EP1102775A1 Novel phospholipids with unsaturated alkyl and acyl chains |
| 05/30/2001 | EP1102768A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 05/30/2001 | EP1102761A2 Cyclopentabenzofuran derivatives and their use |
| 05/30/2001 | EP1102755A1 Substituted isoxazole derivatives as estrogen receptor modulators |
| 05/30/2001 | EP1102754A1 Imidazoles and related compounds as alpha-1a agonists |
| 05/30/2001 | EP1102752A1 Succinoylamino lactams as inhibitors of a beta protein production |
| 05/30/2001 | EP1102751A1 Novel bi- and tri-cyclic aza compounds and their uses |
| 05/30/2001 | EP1102750A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 05/30/2001 | EP1102747A1 Crystalline forms of osanetant |
| 05/30/2001 | EP1102746A1 Substituted phenylamidines with antithrombotic action |
| 05/30/2001 | EP1102743A1 Amide derivatives which are useful as cytokine inhibitors |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
| 05/30/2001 | EP1102596A1 Peptide antagonists of zonulin and methods for use of the same |
| 05/30/2001 | EP1102595A2 Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria |
| 05/30/2001 | EP1102592A1 Coumarin and related aromatic-based polymeric prodrugs |
| 05/30/2001 | EP1102590A1 Use of a nk-1 receptor antagonist for treating or preventing abnormal bone resorption |
| 05/30/2001 | EP1102584A2 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 05/30/2001 | EP1102582A2 Inhibitors of type 3 3alpha-hydroxysteroid dehydrogenase |
| 05/30/2001 | EP1102579A1 Medicinal aerosol formulations |
| 05/30/2001 | EP1032265A4 New psoralens for pathogen inactivation |
| 05/30/2001 | EP0925067A4 Composition and method for repairing neurological tissue |
| 05/30/2001 | EP0689443B1 The use of bisphosphonates in bone surgery |
| 05/30/2001 | EP0672043B1 Novel 4-(3-benzofuranyl)piperidinyl and 4-(3-benzothienyl)piperidinyl derivatives and pharmaceutical compositions containing them |
| 05/30/2001 | EP0660712B1 Transcutaneous in vivo activation of photosensitive agents in blood |
| 05/30/2001 | EP0641320B1 Substituted (s)-3-phenylpiperidine derivatives, their preparation and their use as dopamine autoreceptor antagonists |
| 05/30/2001 | EP0637306B1 4-imidomethyl-1- [2'-phenyl-2'-oxoethyl]- piperidines as serotonin 5ht 2-antagonists, their preparation and use in therapy |
| 05/30/2001 | CN1297532A Identification of chemical active agents for inhibiting 1-desoxy-D-xylulose-5-phosphate biosynthetic pathway in parasites, and said active agents |
| 05/30/2001 | CN1297483A Human protease and use of such protease for pharmaceutical applications and for reducing allergenicity of non-human proteins |
| 05/30/2001 | CN1297454A Novel omega-conotoxin peptides |
| 05/30/2001 | CN1297452A Modified factor VIII |
| 05/30/2001 | CN1297451A Glucocorticoid-selective antiinflammatory agents |
| 05/30/2001 | CN1297442A 5-aminoindeno [1,2-c] pyrazol-4-ones as anti-cancer and anti-proliferative agents |
| 05/30/2001 | CN1297441A Heterocyclically substd. amides used as calpain inhibitors |
| 05/30/2001 | CN1297439A 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists |
| 05/30/2001 | CN1297438A Substd. indolinones having inhibiting effect on kinases and cycline/CDK complexes |
| 05/30/2001 | CN1297436A Substd. pyrrolidine hydroxamate metalloprotease inhibitors |
| 05/30/2001 | CN1297432A Substd. amides, their production and their use |
| 05/30/2001 | CN1297431A Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
| 05/30/2001 | CN1297354A Dipeptide caspase inhibitors and use thereof |
| 05/30/2001 | CN1297351A Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 05/30/2001 | CN1297350A Agents for relieving side effects |
| 05/30/2001 | CN1296841A Extract of Chinese-medicinal herbs and its application |
| 05/30/2001 | CN1296833A Chinese medicinal composition for relieving fatigue |
| 05/30/2001 | CN1296819A Process for preparing multifunctional broad-spectrum medicine of preventing and treating fish diseases |
| 05/30/2001 | CN1296816A Stomach-lavaging agent of sympathin |
| 05/30/2001 | CN1066449C Tricyclic oxime ethers, processes for their preparation and pharmaceutical compositions contg. them |
| 05/30/2001 | CN1066445C Aroyl-piperidine derivs. |
| 05/30/2001 | CN1066436C Cyclohexanes and cyclohexenes derivs. |
| 05/30/2001 | CN1066344C Multi-effect oral liquor for bringing down fever |
| 05/30/2001 | CA2327026A1 Quinoline derivatives useful for inhibiting farnesyl protein transferase |
| 05/29/2001 | US6239288 Biphenyl hydroxy imino butyric acids and their derivatives for treating arthritis |
| 05/29/2001 | US6239284 Skin disorders; anticancer agents |
| 05/29/2001 | US6239265 Oligonucleotides having chiral phosphorus linkages |
| 05/29/2001 | US6239256 Isolated muteins of proteins SCP-1, and compositions containing the mutein |
| 05/29/2001 | US6239176 Administering to treat blood disorders like anemia; wound healing, anticarcinogenic and antiproliferative agents; genetic disorders |
| 05/29/2001 | US6239173 Antiinflammatory, antipyretic, analgesic, and antiarthritic agents |
| 05/29/2001 | US6239172 Mixture of angiogenic growth factor and l-arginine; brain and cardiovascular disorders |
| 05/29/2001 | US6239171 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 05/29/2001 | US6239170 Applying 5-lipoxygenase inhibitor |
| 05/29/2001 | US6239153 Insulin sensitivity enhancer with squaline synthesis inhibitor, which shows a potent depressive effect on diabetic hyperglycemia, |
| 05/29/2001 | US6239147 To treat cns, gastrointestinal and other disorders. substance p antagonists having improved activity and fewer side effects, treatment of emesis induced by antineoplastic agents, isochroman ring |
| 05/29/2001 | US6239146 Neurotrophic difluoroamide agents |
| 05/29/2001 | US6239138 Vitronectin receptor antagonist |
| 05/29/2001 | US6239137 Salts of aminoimidazole carboxamide and 5 amino or substituted amino 1,2,3-triazole, induce apoptosis, inhibit DNA synthesis and control cyclooxygenase activity |
| 05/29/2001 | US6239135 Arylpiperazines having activity at the serotonin 1A receptor |
| 05/29/2001 | US6239132 Thrombin inhibitors |
| 05/29/2001 | US6239130 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 05/29/2001 | US6239129 Characterised by an indole ring on the aromatic moiety by a cyano group and on the indole nitrogen by an aminoalkyl chain. great affinity for 5-ht2c receptors, useful for depression, panic attacks, obsessive-compulsive disorders, phobias, |
| 05/29/2001 | US6239128 Combating diseases and disorders associated with or mediated by the release of excitatory amino acids, associated with reduced blood flow to the brain and other cns tissue, |
| 05/29/2001 | US6239124 Pharmaceutical compositions for the treatment of transplant rejection or autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxyethyl)-rapamycin |
| 05/29/2001 | US6239116 Immunostimulatory nucleic acid molecules |
| 05/29/2001 | US6239106 Family of protease inhibitors, and other biologic active substances |
| 05/29/2001 | US6239102 Concentrate comprising, as active agent, (3'-desoxy-3-oxo-mebmc)1-(val)2-cyclosporin, stabilizer selected from oleic acid or palmitoyl oleoyl phosphatidyl glycerol or salts thereof, ethanol |